ARCHIVES

NCI Announces Designation Of Comprehensive Center

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

Expiring Program Offer Flexibility

February 12, 1982

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

ASCO Recommends End of Life Discussions

January 28, 2011

Hopkins to Commit Own Money for Junior Faculty Research

May 2, 1986

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

July 10, 1992

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004